Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
55.5M
-
Shares change
-
+484K
-
Total reported value, excl. options
-
$156M
-
Value change
-
+$1.09M
-
Put/Call ratio
-
2
-
Number of buys
-
39
-
Number of sells
-
-33
-
Price
-
$2.82
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q2 2024
89 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q2 2024.
Generation Bio Co. - #OTHER (GBIO) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5M shares
of 67M outstanding shares and own 82.79% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.51M shares), Atlas Venture Life Science Advisors, LLC (8.28M shares), FMR LLC (5.3M shares), Bellevue Group AG (3.92M shares), BlackRock Inc. (3.29M shares), BANK OF AMERICA CORP /DE/ (2.98M shares), Artal Group S.A. (2.83M shares), VANGUARD GROUP INC (2.59M shares), EcoR1 Capital, LLC (2.05M shares), and GOLDMAN SACHS GROUP INC (1.28M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.